Document ID: chunk:federal_register_of_legislation:F2024L01037:clause:4_13
Version: federal_register_of_legislation:F2024L01037
Segment Type: clause
Provision Reference: sch 4 cl 13
Character Range: 11073–12050

13  Assay limits
 (1) The following assay limits apply in relation to psilocybine extract products:
           (a) the average content of psilocybine in a pooled sample of not fewer than 20 capsules must be not less than 90.0% and not more than 110.0% of the stated content of psilocybine;
           (b) the average content of psilocin in a pooled sample of not fewer than 20 capsules must be not less 90.0% and not more than 110.0% of the stated content of psilocin;
           (c) the average content of any nominated tryptamines in a pooled sample of not fewer than 20 capsules must be not less than 90.0% and not more than 110.0% of the stated content of the nominated tryptamine.
 (2) The following assay limits apply in relation to a psilocybine isolate product:
           (a) the average content of psilocybine isolate in a pooled sample of not fewer than 20 capsules must be not less than 90.0% and not more than 110.0% of the stated content of psilocybine isolate.